Misc Pharmacy Tech

NIOSH Category 1 Hazardous Drug

antineoplastic drugs known to be hazardous with repeated exposure (most chemotherapies)

NIOSH Category 2 Hazardous Drug

non-antineoplastic drugs that meet criteria for hazardous

NIOSH Category 3 Hazardous Drug

Drugs with adverse effects on reproduction

The Environmental Protection Agency (EPA)

Government Agency that regulates disposal of pharmaceutical waste

National Institute for Occupational Safety & Health (NIOSH)

Organization that provides official list of Antineoplastic medications and hazardous drugs

Hazard Communication Standard (HCS)

Requires health facilities to maintain Safety Data Sheets (SDS) for all chemicals and substances stored and/or used in the workplace, published by OSHA

Resource Conservation and Recovery Act (RCRA)

Regulation that classifies hazardous waste, published by EPA

P- List

Acute Hazardous Waste

U- List

Hazardous waste

DEA Schedule I Drugs

High potential for abuse, no medical use (Illegal drugs)

DEA Schedule II Drugs

High Potential for Abuse, medical use (pain & ADHD)

DEA Schedule III Drugs

Less Potential for Abuse (Testosterone & >90mg codeine)

DEA Schedule IV Drugs

Low abuse potential (Anxiety & Sleep)

DEA Schedule V Drugs

Low abuse potential (Cough & Diarrhea)

DEA form 222

Order form for schedule I and II controlled substances

DEA form 41

Form to request permission from DEA to destroy controlled substances or return damaged/unwanted controlled substances

DEA form 106

Form used to report theft or significant loss of controlled substances

Combat Methamphetamine Epidemic Act of 2005 (CMEA)

limit sales of Pseudoephedrine & ephedrine

Risk Evaluation & Mitigation Strategy (REMS)

Drug safety program issued by FDA to educate healthcare providers and patients about serious risks

Pharmacodynamics

Study of drug effects on the body and how they exert their therapeutic effects.

Pharmacokinetics

Study of how the body effects the drug through absorption, distribution, metabolism, and excretion in the body.

Agonists

Substances that activate receptors to produce a biological response.

Antagonists

Substances that inhibit or block receptors, preventing a biological response.

Bioavailability

The fraction of an administered dose of a drug that reaches the systemic circulation in an active form.

Orange Book

A reference that contains information on drug products, including therapeutically equivalent generic alternatives.

Purple Book

A reference that provides information on biological products, including biosimilar products and their interchangeability.

Enteral

refers to the administration of medication through the gastrointestinal tract, typically via oral or rectal routes.

Parenteral

refers to the administration of medication by any route other than the gastrointestinal tract, commonly through injections such as intravenous or intramuscular.

IV Push

a method of administering medication directly into the bloodstream via an intravenous line, often used for rapid delivery.

IV Infusion

is the continuous administration of medication or fluids directly into the bloodstream through an intravenous line, allowing for controlled delivery over a specified duration.

Red Book

A Reference that contains wholesale and retail pricing for prescription & OTC drugs

Durham-Humphrey Amendment

Federal law that defines prescription & OTC medications

Class I Recall

A classification indicating that a product may cause serious harm or death. It involves the removal of the product from the market.

Class II Recall

A classification indicating that a product may cause temporary or medically reversible harm, or where the probability of serious harm is remote. It generally involves a notification to physicians and consumers.

Class III Recall

A classification indicating that a product is unlikely to cause harm but violates FDA regulations. It typically involves a public notification or product correction.

OBRA-90

A federal law enacted to improve the quality of care in nursing homes and ensure the safe use of medications by requiring drug utilization reviews and patient counseling.

Pregnancy Category A

A classification for drugs that are considered safe for use during pregnancy, with no risk to the fetus in studies.

Pregnancy Category B

A classification for drugs that may pose some risk to the fetus, but the benefits may outweigh the risks if used properly.

Pregnancy Category C

A classification for drugs that are contraindicated in pregnancy due to demonstrated risk to the fetus, but may be used in life-threatening situations if no safer alternatives exist.

Pregnancy Category D

A classification for drugs that may cause harm to the fetus based on human or animal studies but can be used in certain situations where the benefits justify the risks.

Pregnancy Category X

A classification for drugs that are contraindicated in pregnancy due to evidence of fetal abnormalities or risks that clearly outweigh any potential benefit.

Error of Comission

An act of providing incorrect or misleading information due to an action taken, often resulting in harm or adverse effects.

Error of Omission

An act of failing to provide necessary information or taking required actions, which can lead to negative outcomes or harm.

NPI Number

A unique 10-digit identifier assigned to healthcare providers in the United States, used for billing and identification purposes.

Medicare Part A

The portion of Medicare that covers inpatient hospital stays, skilled nursing facility care, hospice, and some home health care.

Medicare Part B

The portion of Medicare that covers outpatient doctor visits, preventive services, and some home health care.

Medicare Part C

The portion of Medicare that allows private insurance companies to provide Medicare benefits, often including additional services like vision and dental.

Medicare Part D

The portion of Medicare that provides prescription drug coverage to beneficiaries, helping to lower their medication costs. It covers medications and vaccines

DAW 0

"Dispense as written" instructions indicating no substitutions.

DAW 1

Instructions to dispense the brand name drug as prescribed, allowing for substitutions only if the patient agrees.

DAW 2

Instructions to dispense a generic drug if available, with no substitutions allowed.

DAW 3

Instructions to dispense the brand name drug as prescribed without allowing for any substitutions.

DAW 4

Instructions to dispense a generic drug as prescribed, allowing for substitutions if requested by the patient.